Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Of Interest
Protein linked to Parkinson’s also found to drive melanoma growth
A small protein involved in neurodegeneration leading to Parkinson’s disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Harnessing the Microbiome to Treat Melanoma: Can It Work?
ATHENS, Greece — Two strategies under investigation suggest that manipulating the gut microbiome could improve the effectiveness of immunotherapy in patients with melanoma, according to new research presented at the 11th World Congress of Melanoma (WCM) and 21st EADO Congress 2025.